Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.20 (
alpha-glucosidase
)
4,237
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chemical galactosylation of human liver tissue lysosomal alpha-glucosidase was carried out. As a result of the modification some physicochemical properties of the enzyme were altered, while its stability and catalytic activity were maintained. An ability of the galactosylated
alpha-glucosidase
to interact with
asialoglycoprotein receptor
from mice liver tissue was studied in vitro. The reaction required Ca2+. A specific inhibitor of the receptor, N-acetyl galactosamine, as well as high concentrations of native glycoproteins and neoglycoproteins containing terminal galactose inhibited the receptor binding of the 125I-galactosylated
alpha-glucosidase
. Native
alpha-glucosidase
was not bound with the receptor. Antireceptor antibodies inhibited similarly binding of both native ligand, asialoorosomucoid and the galactosylated
alpha-glucosidase
. These data on specific interaction between the galactosylated form of
alpha-glucosidase
and
asialoglycoprotein receptor
are discussed in connection with the problem of directed transport of the enzyme into liver parenchymatous cells by means of receptor-dependent endocytosis, which may be of importance in development of enzymotherapy of hereditary lysosomal enzymopathies.
...
PMID:[Chemical galactosylation of acid alpha-glucosidase to provide directed transport of the enzyme into lysosomes of liver parenchymal cells]. 282 27
An
asialoglycoprotein receptor
was isolated from murine liver and purified more than 1600-fold using 2-fold affinity chromatography on asialoorosomucoid-Sepharose. The purified receptor did not interact with 125I-orosomucoid, but bound to 125I-asialoorosomucoid. The binding of the receptor to asialoorosomucoid was saturable. The dissociation constant of the receptor-asialoorosomucoid complex was 0.4 X 10(-9) M. The molecular mass of the receptor, as determined with the use of specific antibodies by the immunoblotting method, was 43 kDa. High concentrations of unlabeled asialoorosomucoid and of n-aminophenyl-beta-D-galactosyl derivatives of bovine serum albumin, ovalbumin and acid alpha-glucosidase from human liver inhibited the binding of the receptor to 125I-asialoorosomucoid almost completely. The binding of the receptor to 125I-galactolyzed
alpha-glucosidase
was pH-dependent, with the pH optimum at 8.0-9.0. It was shown that, as in the case of 125I-asialoorosomucoid, the binding of the 125I-galactosyl derivative of
alpha-glucosidase
occurred in the presence of Ca2+ and was inhibited by N-acetylgalactosamine. Glycoproteins containing galactose as a terminal residue inhibited the interaction of the receptor with 125I-galactolyzed
alpha-glucosidase
. The possibility of directed transport of the galactolyzed
alpha-glucosidase
derivative into parenchymous liver cells using receptor-mediated endocytosis is discussed.
...
PMID:Interaction of hepatic asialoglycoprotein receptor with asialoorosomucoid and galactolyzed lysosomal alpha-glucosidase. 352 76